Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Radiation therapy uses high energy x-rays to kill tumor cells. Capecitabine may also make
tumor cells more sensitive to radiation therapy. Giving radiation together with capecitabine
after surgery may kill any remaining tumor cells.
PURPOSE: This phase II trial is studying the side effects and how well giving capecitabine
together with radiation therapy works in treating patients with nonmetastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Simmons Cancer Center University of Texas Southwestern Medical Center